A detailed history of State Of Wisconsin Investment Board transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 65,266 shares of RARE stock, worth $2.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
65,266
Previous 70,570 7.52%
Holding current value
$2.89 Million
Previous $2.9 Million 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.21 - $59.36 $213,273 - $314,845
-5,304 Reduced 7.52%
65,266 $3.63 Million
Q2 2024

Aug 14, 2024

BUY
$37.42 - $51.61 $738,895 - $1.02 Million
19,746 Added 38.85%
70,570 $2.9 Million
Q1 2024

May 14, 2024

SELL
$43.02 - $53.69 $209,636 - $261,631
-4,873 Reduced 8.75%
50,824 $2.37 Million
Q4 2023

Feb 12, 2024

SELL
$31.73 - $49.19 $28,430 - $44,074
-896 Reduced 1.58%
55,697 $2.66 Million
Q3 2023

Nov 14, 2023

SELL
$34.92 - $46.66 $84,436 - $112,823
-2,418 Reduced 4.1%
56,593 $2.02 Million
Q2 2023

Aug 14, 2023

SELL
$37.35 - $52.15 $91,171 - $127,298
-2,441 Reduced 3.97%
59,011 $2.72 Million
Q1 2023

May 15, 2023

SELL
$36.99 - $48.71 $197,637 - $260,257
-5,343 Reduced 8.0%
61,452 $2.46 Million
Q4 2022

Feb 14, 2023

SELL
$33.72 - $46.33 $20,872 - $28,678
-619 Reduced 0.92%
66,795 $3.09 Million
Q3 2022

Nov 14, 2022

SELL
$39.96 - $66.14 $113,606 - $188,036
-2,843 Reduced 4.05%
67,414 $2.79 Million
Q2 2022

Aug 15, 2022

BUY
$45.8 - $85.4 $547,126 - $1.02 Million
11,946 Added 20.49%
70,257 $4.19 Million
Q1 2022

May 13, 2022

BUY
$62.2 - $84.4 $3.13 Million - $4.25 Million
50,359 Added 633.29%
58,311 $4.24 Million
Q4 2021

Feb 11, 2022

SELL
$73.71 - $87.86 $9,287 - $11,070
-126 Reduced 1.56%
7,952 $669,000
Q3 2021

Nov 12, 2021

BUY
$77.92 - $102.4 $29,765 - $39,116
382 Added 4.96%
8,078 $729,000
Q2 2021

Aug 12, 2021

SELL
$92.19 - $115.71 $7.17 Million - $9 Million
-77,804 Reduced 91.0%
7,696 $734,000
Q1 2021

May 17, 2021

SELL
$106.9 - $167.73 $160,350 - $251,594
-1,500 Reduced 1.72%
85,500 $9.74 Million
Q4 2020

Feb 03, 2021

SELL
$84.4 - $177.39 $337,600 - $709,560
-4,000 Reduced 4.4%
87,000 $12 Million
Q2 2020

Aug 12, 2020

BUY
$46.91 - $78.22 $314,297 - $524,074
6,700 Added 7.95%
91,000 $7.12 Million
Q1 2020

May 06, 2020

BUY
$33.8 - $62.9 $87,879 - $163,540
2,600 Added 3.18%
84,300 $3.75 Million
Q3 2019

Nov 12, 2019

BUY
$42.5 - $63.11 $225,250 - $334,483
5,300 Added 6.94%
81,700 $3.5 Million
Q2 2019

Aug 14, 2019

BUY
$54.93 - $74.36 $554,793 - $751,036
10,100 Added 15.23%
76,400 $4.85 Million
Q1 2019

May 13, 2019

BUY
$39.87 - $69.36 $713,673 - $1.24 Million
17,900 Added 36.98%
66,300 $4.6 Million
Q4 2018

Feb 11, 2019

SELL
$38.89 - $77.3 $15,556 - $30,920
-400 Reduced 0.82%
48,400 $2.1 Million
Q2 2018

Aug 03, 2018

BUY
$48.54 - $85.31 $405,551 - $712,765
8,355 Added 20.66%
48,800 $3.75 Million
Q3 2017

Nov 01, 2017

BUY
$49.79 - $66.32 $2.01 Million - $2.68 Million
40,445
40,445 $2.15 Million

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.1B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.